| Product NDC: | 49349-486 |
| Proprietary Name: | Ribasphere |
| Non Proprietary Name: | RIBAVIRIN |
| Active Ingredient(s): | 400 mg/1 & nbsp; RIBAVIRIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49349-486 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077456 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110818 |
| Package NDC: | 49349-486-34 |
| Package Description: | 27 TABLET in 1 BLISTER PACK (49349-486-34) |
| NDC Code | 49349-486-34 |
| Proprietary Name | Ribasphere |
| Package Description | 27 TABLET in 1 BLISTER PACK (49349-486-34) |
| Product NDC | 49349-486 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RIBAVIRIN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110818 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | RIBAVIRIN |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |